Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001390478-14-000032
Filing Date
2014-07-02
Accepted
2014-07-02 14:30:15
Documents
1
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3198
  Complete submission text file 0001390478-14-000032.txt   4906
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET WORCESTER MA 01605
Business Address
SCHWARTZ MARK W. (Reporting) CIK: 0001422882 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 14955813